Susquehanna Fundamental Investments, LLC Xencor Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $757,851 - $882,223	-24,726 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$34.33 - $44.68 $226,989 - $295,424	-6,612 Reduced 21.1%	24,726 $853,000
Q1 2021 May 17, 2021	SELL	$40.81 - $53.88 $261,102 - $344,724	-6,398 Reduced 16.95%	31,338 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $278,754 - $362,464	7,610 Added 25.26%	37,736 $1.65 Million
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $906,491 - $1.3 Million	30,126 New	30,126 $1.17 Million

204

63.1M

3.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.28B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.